Page results
-
This page has been written for parents of children who have been diagnosed with congenital cytomegalovirus (cCMV) infection.
-
There are rail strikes currently planned for Wednesday 27, Saturday 31 of July.
-
Trial of T-cell therapy for lung cancer begins at UCLH
-
Read more about the NHS Staff Survey 2024 - we’re the top acute trust to work at for third year running!
-
The Clinical Research Facility at UCLH has been awarded £10 million in funding to deliver cutting edge early phase health research in areas including cancer and dementia.
-
People with the acquired communication disorder aphasia – which involves problems with the understanding or production of speech –have benefitted greatly from a two-year programme of therapy at the National Hospital for Neurology and Neurosurgery at UCLH.
-
Information about our UCLH Charity, charity funds and associated charities.
-
UCLH has recruited the first participant for a new UK based study for Parkinson’s Disease (PD). The ASPro-PD study is testing whether treatment with a drug called ambroxol is associated with an improvement in motor and non-motor function compared with placebo.
-
The NHS has become the first healthcare system in the world to provide a new blood group genotyping test which is set to transform care for patients living with sickle cell disorder and thalassaemia.
File results
-
FOI/2023/0371 - Long Covid paediatric hub
-
FOI/2022/0266 - Drug Patient Level Contract Monitoring (DrPLCM)/ SACT cancer report
-
FOI/2023/0374 - Stillbirths, neonatal deaths, maternal deaths at Trust from 2018 - 2022
-
FOI/2023/0376 - Director of Estate and Facilities/ Head of Patient Experience contact details
-
FOI/2023/0379 - MDT meetings in relation to tailgut cysts
-
FOI/2023/0380 - Flexible nurse bank rates/ spend March 2023
-
FOI/2023/0383 - Cataract referrals
-
FOI/2023/0384 - Cyber security attacks 2020-2022
-
FOI/2023/0386 - Sickle Cell staffing and patients
-
FOI/2023/0392 - Treatment/ medication for biologic medicines in gastroenterology